NuVasive Inc Contracts & Agreements

First Supplemental Indenture, dated September 1, 2023 (Filed With SEC on September 1, 2023)

First Amendment to the NuVasive, Inc. Amended and Restated Executive Severance Plan (Filed With SEC on May 10, 2023)

NuVasive, Inc. Excise Tax Gross-Up Plan (Filed With SEC on May 10, 2023)

Form of Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2023 (Filed With SEC on May 10, 2023)

Amendment No. 2 to Credit Agreement, dated as of May 8, 2023, by and among NuVasive, Inc., certain of its subsidiaries, as guarantors, Bank of America, N.A., as administrative... (Filed With SEC on May 10, 2023)

Agreement and Plan of Merger, dated as of February 8, 2023, by and among NuVasive, Inc., Globus Medical, Inc. and Zebra Merger Sub, Inc (Filed With SEC on February 9, 2023)

Voting and Support Agreement, dated as of February 8, 2023, by and among NuVasive, Inc., Globus Medical, Inc., David Paul and Sonali Paul (Filed With SEC on February 9, 2023)

Amendment No. 2 to 2004 Amended and Restated Employee Stock Purchase Plan of NuVasive, Inc (Filed With SEC on November 9, 2022)

Employment Letter dated August 22, 2022 between the Company and Michael Farrington (Filed With SEC on November 9, 2022)

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after March 1, 202 (Filed With SEC on May 4, 2022)

Form of Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 202 (Filed With SEC on May 4, 2022)

Separation Agreement and General Release dated November 8, 2021 between the Company and Brent Boucher (Filed With SEC on February 23, 2022)

Employment Letter dated January 14, 2022 between the Company and Andrew C. Morton (Filed With SEC on February 23, 2022)

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after March 1, 2021 (Filed With SEC on May 5, 2021)

Form of Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2021 (Filed With SEC on May 5, 2021)

Separation Agreement and General Release dated January 28, 2021 between the Company and Matthew Link (Filed With SEC on February 25, 2021)

Employment Letter dated January 1, 2019 between the Company and Lucas Vitale (Filed With SEC on February 25, 2021)

Employment Letter dated October 25, 2019 between the Company and Dale Wolf (Filed With SEC on February 25, 2021)

Amendment Agreement dated as of October 26, 2020, between Morgan Stanley & Co. International plc and the Company (Filed With SEC on October 29, 2020)

Amendment Agreement dated as of October 26, 2020, between Royal Bank of Canada and the Company (Filed With SEC on October 29, 2020)

Amendment Agreement dated as of October 26, 2020, between Bank of America, N.A. and the Company (Filed With SEC on October 29, 2020)

Amendment Agreement dated as of October 26, 2020, between Barclays Bank PLC and the Company (Filed With SEC on October 29, 2020)

Employment Letter dated October 14, 2020 between the Company and Massimo Calafiore (Filed With SEC on October 29, 2020)

Employment Letter dated October 13, 2020 between the Company and Brent Boucher (Filed With SEC on October 29, 2020)

Employment Letter Agreement dated October 13, 2020 between the Company and Matt Link (Filed With SEC on October 29, 2020)

General Consulting and Services Agreement dated October 13, 2020 between the Company and Matt Link (Filed With SEC on October 29, 2020)

Amendment No. 1 to Proprietary Information, Inventions Assignment and Restrictive Covenant Agreement dated October 13, 2020 between the Company and Matt Link (Filed With SEC on October 29, 2020)

Confirmation for additional call option transaction dated as of June 2, 2020, between Morgan Stanley & Co. International plc and the Company (Filed With SEC on June 4, 2020)

Confirmation for additional call option transaction dated as of June 2, 2020, between Royal Bank of Canada and the Company (Filed With SEC on June 4, 2020)

Confirmation for additional call option transaction dated as of June 2, 2020, between Bank of America, N.A. and the Company (Filed With SEC on June 4, 2020)

Confirmation for additional call option transaction dated as of June 2, 2020, between Barclays Bank PLC and the Company (Filed With SEC on June 4, 2020)

Confirmation for additional warrant transaction dated as of June 2, 2020, between Morgan Stanley & Co. International plc and the Company (Filed With SEC on June 4, 2020)

Confirmation for additional warrant transaction dated as of June 2, 2020, between Royal Bank of Canada and the Company (Filed With SEC on June 4, 2020)

Confirmation for additional warrant transaction dated as of June 2, 2020, between Bank of America, N.A. and the Company (Filed With SEC on June 4, 2020)

Confirmation for additional warrant transaction dated as of June 2, 2020, between Barclays Bank PLC and the Company (Filed With SEC on June 4, 2020)

Indenture dated as of June 1, 2020 between the Company and the Trustee (Filed With SEC on June 1, 2020)

Confirmation for base call option transaction dated as of May 27, 2020, between Morgan Stanley & Co. International plc and the Company (Filed With SEC on June 1, 2020)

Confirmation for base call option transaction dated as of May 27, 2020, between Royal Bank of Canada and the Company (Filed With SEC on June 1, 2020)

Confirmation for base call option transaction dated as of May 27, 2020, between Bank of America, N.A. and the Company (Filed With SEC on June 1, 2020)

Confirmation for base call option transaction dated as of May 27, 2020, between Barclays Bank PLC and the Company (Filed With SEC on June 1, 2020)

Confirmation for base warrant transaction dated as of May 27, 2020, between Morgan Stanley & Co. International plc and the Company (Filed With SEC on June 1, 2020)

Confirmation for base warrant transaction dated as of May 27, 2020, between Royal Bank of Canada and the Company (Filed With SEC on June 1, 2020)

Confirmation for base warrant transaction dated as of May 27, 2020, between Bank of America, N.A. and the Company (Filed With SEC on June 1, 2020)

Confirmation for base warrant transaction dated as of May 27, 2020, between Barclays Bank PLC and the Company (Filed With SEC on June 1, 2020)

Amendment No. 1 to Credit Agreement, dated as of May 26, 2020, by and among NuVasive, Inc., Bank of America, N.A. and each of those additional Lenders that are a party to such... (Filed With SEC on May 26, 2020)

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after March 1, 2020 (Filed With SEC on May 6, 2020)

Form of Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2020 (Filed With SEC on May 6, 2020)

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2020 (Filed With SEC on May 6, 2020)

Form of Temporary Reduction of Compensation Letter dated as of April 13, 2020 between the Company and its directors and executive officers (Filed With SEC on May 6, 2020)

Separation Agreement and General Release dated as of May 4, 2020, between the Company and Rajesh J. Asarpota (Filed With SEC on May 6, 2020)

Confirmation for base call option transaction dated as of February 26, 2020, between Morgan Stanley & Co. International plc and the Company (Filed With SEC on March 2, 2020)

Confirmation for base call option transaction dated as of February 26, 2020, between JPMorgan Chase Bank, National Association and the Company (Filed With SEC on March 2, 2020)

Confirmation for base call option transaction dated as of February 26, 2020, between Royal Bank of Canada and the Company (Filed With SEC on March 2, 2020)

Confirmation for base call option transaction dated as of February 26, 2020, between The Bank of Nova Scotia and the Company (Filed With SEC on March 2, 2020)

Confirmation for base call option transaction dated as of February 26, 2020, between Barclays Bank PLC and the Company (Filed With SEC on March 2, 2020)

Confirmation for base warrant transaction dated as of February 26, 2020, between Morgan Stanley & Co. International plc and the Company (Filed With SEC on March 2, 2020)

Confirmation for base warrant transaction dated as of February 26, 2020, between JPMorgan Chase Bank, National Association and the Company (Filed With SEC on March 2, 2020)

Confirmation for base warrant transaction dated as of February 26, 2020, between Royal Bank of Canada and the Company (Filed With SEC on March 2, 2020)

Confirmation for base warrant transaction dated as of February 26, 2020, between The Bank of Nova Scotia and the Company (Filed With SEC on March 2, 2020)

Confirmation for base warrant transaction dated as of February 26, 2020, between Barclays Bank PLC and the Company (Filed With SEC on March 2, 2020)

Amendment Agreement, dated February 26, 2020, between the Company and Bank of America, N.A (Filed With SEC on March 2, 2020)

Indenture dated as of March 2, 2020 between the Company and the Trustee (Filed With SEC on March 2, 2020)

Description of Registrants Securities (Filed With SEC on February 20, 2020)

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after March 1, 2019 (Filed With SEC on February 20, 2020)

Form of Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2019 (Filed With SEC on February 20, 2020)

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) for grants on or after March 1, 2019 (Filed With SEC on February 20, 2020)

Employment Letter dated December 27, 2019 between the Company and Matthew K. Harbaugh (Filed With SEC on February 20, 2020)

Employment Letter dated June 19, 2018 between the Company and Nathaniel B. Sisitsky, Esq (Filed With SEC on February 20, 2020)

Employment Letter dated February 25, 2019 between the Company and Paul D. McClintock (Filed With SEC on February 20, 2020)

Employment Letter dated November 11, 2019 between the Company and Paul D. McClintock (Filed With SEC on February 20, 2020)

Employment Letter dated December 31, 2019 between the Company and Rajesh Asarpota (Filed With SEC on February 20, 2020)

General Consulting and Services Agreement dated December 31, 2019 between the Company and Rajesh Asarpota (Filed With SEC on February 20, 2020)

Non-Employee Director Cash Compensation Plan (Filed With SEC on February 20, 2020)

General Consulting and Services Agreement effective December 31, 2018 between the Company and Stephen Rozow (Filed With SEC on May 1, 2019)

Separation Agreement and General Release dated December 31, 2018 between the Company and Stephen Rozow (Filed With SEC on May 1, 2019)

Amendment No. 1 to Proprietary Information, Inventions Assignment and Restrictive Covenant Agreement effective December 31, 2018 between the Company and Stephen Rozow (Filed With SEC on May 1, 2019)

General Consulting and Services Agreement effective June 28, 2018 between the Company and Joan Stafslien (Filed With SEC on May 1, 2019)

Separation Agreement and General Release dated June 28, 2018 between the Company and Joan Stafslien (Filed With SEC on May 1, 2019)

Amendment No. 1 to 2004 Amended and Restated Employee Stock Purchase Plan of NuVasive, Inc (Filed With SEC on February 20, 2019)

Assignment and Novation Agreement effective November 12, 2018 by and among Gregory T. Lucier, River Road Capital Partners, LLC and the Company (Filed With SEC on February 20, 2019)

Notice of Grant of Performance Cash Award and Award Agreement granted to Matthew Link on December 3, 2018 (Filed With SEC on February 20, 2019)

Form of Performance Restricted Stock Unit Agreement (with accompanying Notice of Grant) for grants on or after April 30, 2018 (Filed With SEC on May 1, 2018)

Form of Executive Restricted Stock Unit Agreement (with accompanying Form Notice of Grant) for grants on or after April 30, 2018 (Filed With SEC on May 1, 2018)

Form of Performance Cash Award Agreement (with accompanying Form Notice of Grant) for grants on or after April 30, 2018 (Filed With SEC on May 1, 2018)

WARRANT TERMINATION AGREEMENT dated as of May 24, 2017 Between NUVASIVE, INC. and BANK OF AMERICA, N.A. (Filed With SEC on July 27, 2017)

WARRANT TERMINATION AGREEMENT dated as of May 24, 2017 Between NUVASIVE, INC. and GOLDMAN SACHS & CO. LLC (F/K/A GOLDMAN, SACHS & CO.) (Filed With SEC on July 27, 2017)

NUVASIVE, INC. AMENDED AND RESTATED EXECUTIVE SEVERANCE PLAN (Filed With SEC on July 27, 2017)

[FORM OF] NUVASIVE, INC. NOTICE OF GRANT OF PERFORMANCE RESTRICTED STOCK UNITS (Filed With SEC on February 9, 2017)

[FORM OF] NUVASIVE, INC. NOTICE OF GRANT OF EXECUTIVE RESTRICTED STOCK UNITS (Filed With SEC on February 9, 2017)

[FORM OF] NUVASIVE, INC. NOTICE OF GRANT OF PERFORMANCE CASH AWARD (Filed With SEC on February 9, 2017)

SETTLEMENT AND PATENT LICENSE AGREEMENT (Filed With SEC on October 26, 2016)

7475 Lusk Boulevard, San Diego, CA 92121 Main ###-###-#### Toll Free ###-###-#### Fax ###-###-#### WWW.NUVASIVE.COM (Filed With SEC on October 26, 2016)

NUVASIVE, INC. NOTICE OF GRANT OF SHARE PURCHASE MATCHING PERFORMANCE RESTRICTED STOCK UNITS (Filed With SEC on October 26, 2016)

AGREEMENT AND PLAN OF MERGER BY AND AMONG NUVASIVE,INC., BIONIC ACQUISITION CORPORATION, BNN HOLDINGS CORP., AND GPP I-BNN, LLC, ASSECURITYHOLDERS AGENT June 6, 2016 TABLE OF... (Filed With SEC on July 5, 2016)

NUVASIVE, INC. AND WILMINGTON TRUST, NATIONAL ASSOCIATION Trustee Indenture Dated as of March 16, 2016 2.25%Convertible Senior Notes due 2021 TABLE OF CONTENTS (Filed With SEC on March 16, 2016)

GOLDMAN, SACHS & CO. | 200 WEST STREET | NEW YORK, NEW YORK 10282-2198 | TEL: 212 ###-###-#### (Filed With SEC on March 16, 2016)

AMENDMENTNO. 1 TO CREDIT AGREEMENT (Filed With SEC on March 9, 2016)

NUVASIVE, INC. NOTICE OF GRANT OF PERFORMANCE RESTRICTED STOCK UNITS (Filed With SEC on February 11, 2016)

NUVASIVE, INC. NOTICE OF GRANT OF EXECUTIVE RESTRICTED STOCK UNITS (Filed With SEC on February 11, 2016)

NUVASIVE, INC. NOTICE OF GRANT OF PERFORMANCE CASH AWARD (Filed With SEC on February 11, 2016)

AGREEMENT ANDPLAN OF MERGER BY AND AMONG ELLIPSETECHNOLOGIES, INC., NUVASIVE, INC., MAGNETO ACQUISITION CORPORATION AND FORTIS ADVISORS LLC (SOLELY IN ITS CAPACITYAS THE... (Filed With SEC on February 11, 2016)

NUVASIVE, INC. NOTICEOF GRANT OF SHARE PURCHASE MATCHING PERFORMANCE RESTRICTED STOCK UNITS (Filed With SEC on May 26, 2015)

NUVASIVE, INC. NOTICEOF GRANT OF PERFORMANCE RESTRICTED STOCK UNITS (Filed With SEC on May 26, 2015)

NUVASIVE, INC. NOTICE OF GRANT OF PERFORMANCE RESTRICTED STOCK UNITS (Filed With SEC on May 4, 2015)

NUVASIVE, INC. NOTICE OF GRANT OF EXECUTIVE RESTRICTED STOCK UNITS (Filed With SEC on May 4, 2015)

NUVASIVE, INC. NOTICE OF GRANT OF PERFORMANCE CASH AWARD (Filed With SEC on May 4, 2015)

SEPARATION AGREEMENT AND RELEASE (Filed With SEC on April 1, 2015)

CONSULTING AGREEMENT (Filed With SEC on April 1, 2015)

AMENDMENT NO. 5 TO 2004 EMPLOYEE STOCK PURCHASE PLAN OF NUVASIVE, INC. (Filed With SEC on April 30, 2014)

TRANSITION SERVICES AGREEMENT (Filed With SEC on April 29, 2014)

Amendment No. 1 To the Amended and Restated 2004 Equity Incentive Plan of NuVasive, Inc. (Filed With SEC on March 3, 2014)

AMENDMENT NO. 4 TO 2004 EMPLOYEE STOCK PURCHASE PLAN OF NUVASIVE, INC. (Filed With SEC on March 3, 2014)

NuVasive, Inc. Non-Employee Director Cash Compensation (Filed With SEC on March 3, 2014)

Amendment # 1 To the Amended and Restated 2004 Equity Incentive Plan of NuVasive, Inc. (Filed With SEC on July 30, 2013)

SETTLEMENT AND LICENSE AGREEMENT (Filed With SEC on July 30, 2013)

AMENDMENT NO. 3 TO 2004 EMPLOYEE STOCK PURCHASE PLAN OF NUVASIVE, INC. Effective May 1, 2012 (Filed With SEC on February 27, 2013)

2004 AMENDED AND RESTATED EQUITY INCENTIVE PLAN OF NUVASIVE, INC. (Filed With SEC on July 26, 2012)

AMENDMENT NO. 2 TO 2004 EMPLOYEE STOCK PURCHASE PLAN OF NUVASIVE, INC. Effective July 22, 2011 (Filed With SEC on February 27, 2012)

Amendment to 2004 Equity Incentive Plan of NuVasive, Inc. (Filed With SEC on November 4, 2011)

AGREEMENT AND PLAN OF MERGER BY AND AMONG NUVASIVE, INC., CATAMARAN ACQUISITION CORPORATION, IMPULSE MONITORING, INC. AND TULLIS-DICKERSON & CO., INC., AS STOCKHOLDERS AGENT... (Filed With SEC on October 7, 2011)

EX-101 INSTANCE DOCUMENT (Filed With SEC on August 5, 2011)

NUVASIVE, INC. (a Delaware corporation) $350,000,000 Convertible Senior Notes due 2017 UNDERWRITING AGREEMENT Dated: June 22, 2011 NUVASIVE, INC. (a Delaware corporation)... (Filed With SEC on June 29, 2011)

NUVASIVE, INC. AND U.S. BANK NATIONAL ASSOCIATION Trustee Indenture Dated as of June 28, 2011 2.75%Convertible Senior Notes due 2017 TABLE OF CONTENTS (Filed With SEC on June 29, 2011)

EX-101 INSTANCE DOCUMENT (Filed With SEC on May 6, 2011)

EX-101 INSTANCE DOCUMENT (Filed With SEC on February 25, 2011)

EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on January 6, 2011)

NeuroVision a proprietary software-driven nerve avoidance system (Filed With SEC on February 26, 2010)

Financial Statements (Filed With SEC on November 6, 2009)

Current assets (Filed With SEC on August 6, 2009)

Current assets (Filed With SEC on May 8, 2009)

NeuroVision a proprietary software-driven nerve avoidance system (Filed With SEC on March 2, 2009)

Current assets (Filed With SEC on November 7, 2008)

Current assets (Filed With SEC on August 8, 2008)

Current assets (Filed With SEC on May 9, 2008)

Current assets (Filed With SEC on November 8, 2007)

Agreed to: Agreed to:Customer Company name: International Business Machines Corporation By /s/ Alexis V. Lukianov By /s/ Authorized Signatory Authorized signature Authorized... (Filed With SEC on August 8, 2007)

IBM Global Services Proposal for IBM Express Solution for SAP Medical Devices Prepared for NuVasive, Inc. (Filed With SEC on August 8, 2007)

NeuroVision a proprietary software-driven nerve avoidance system (Filed With SEC on March 15, 2007)

ASSET PURCHASE AGREEMENT (Filed With SEC on January 25, 2007)

Exhibit No (Filed With SEC on January 9, 2007)

Exhibit No (Filed With SEC on September 29, 2006)

Current assets (Filed With SEC on August 8, 2006)

Exhibit No (Filed With SEC on May 30, 2006)

NeuroVision a proprietary software-driven nerve avoidance system (Filed With SEC on March 15, 2006)

7,500,000 Shares Common Stock UNDERWRITING AGREEMENT dated February 1,2006 Banc of America Securities LLC (Filed With SEC on February 7, 2006)

As Accepted and Agreed: (Filed With SEC on December 7, 2005)

Purchase and Sale of the Intellectual PropertyRights (Filed With SEC on August 17, 2005)

INTELLECTUAL PROPERTY PURCHASE AGREEMENT ADDENDUM (Filed With SEC on August 17, 2005)

ASSET PURCHASE AGREEMENT AMONG NUVASIVE, INC. PEARSALLS LIMITED AND AMERICAN MEDICAL INSTRUMENTS HOLDINGS, INC. AUGUST 4, 2005 (Filed With SEC on August 10, 2005)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on August 10, 2005)

EXCLUSIVE MANUFACTURING AGREEMENT (Filed With SEC on August 10, 2005)

ASSET PURCHASE AGREEMENT BETWEEN NUVASIVE, INC. AND RSB SPINE LLC JUNE 3, 2005 (Filed With SEC on June 9, 2005)

CONFIDENTIAL TREATMENT REQUESTED (Filed With SEC on January 21, 2005)

SUBLEASE (Filed With SEC on November 15, 2004)

Category

Industry

Companies

Contracts

NuVasive Inc Contracts & Agreements